Clinical Study of Efficacy and Safety of Chidamide Combined With Cladribine Regimen in Refractory/Relapsed Acute Myeloid Leukemia
Latest Information Update: 04 Apr 2024
At a glance
- Drugs Cladribine (Primary) ; Tucidinostat (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 19 Apr 2022 New trial record